NCT00002144View on ClinicalTrials.gov

The Pilot Study of Foscarnet Cream in the Treatment of Mucocutaneous Herpes Simplex Virus Infections in Immunocompromised Patients Unresponsive to Acyclovir Treatment

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

Not specified

Conditions
Herpes SimplexHIV Infections
Interventions
DRUG

Foscarnet sodium

Trial Locations (8)

10016

Bellevue Hosp Ctr, New York

20037

George Washington Univ Med Ctr, Washington D.C.

33143

South Miami Hosp, Miami

44106

Univ Hosps of Cleveland, Cleveland

53226

Milwaukee County Med Complex, Milwaukee

60610

Dr Thomas Klein, Chicago

90095

CARE Ctr / UCLA Med Ctr, Los Angeles

02908

Roger Williams Med Ctr, Providence

Sponsors

Lead Sponsor

Astra USA
All Listed Sponsors
lead

Astra USA

INDUSTRY

NCT00002144 - The Pilot Study of Foscarnet Cream in the Treatment of Mucocutaneous Herpes Simplex Virus Infections in Immunocompromised Patients Unresponsive to Acyclovir Treatment | Biotech Hunter | Biotech Hunter